Ilizarov
Payments companies reported to CMS as associated with Ilizarov. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ilizarov, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ilizarov
These are the largest totals companies reported as associated with Ilizarov. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stuart Green | Los Alamitos, CA | $52,066.33 | |
| John Watson | Saint Louis, MO | Orthopaedic Surgery | $21,738.55 |
| Bradley Lamm | West Palm Beach, FL | Foot and Ankle Surgery | $17,734.72 |
| Stuart Gold | Torrance, CA | Orthopaedic Surgery | $16,457.34 |
| Stephen Quinnan | West Palm Beach, FL | Orthopaedic Surgery | $15,459.06 |
| James Blair | Augusta, GA | Orthopaedic Trauma | $14,362.90 |
| Brian Mullis | Indianapolis, IN | Orthopaedic Surgery | $13,738.31 |
| John Wyrick | Cincinnati, OH | Orthopaedic Surgery | $13,401.45 |
| Gabriel Gambardella | Bloomfield, CT | Foot & Ankle Surgery | $13,312.50 |
| Paul Fortin | Royal Oak, MI | Orthopaedic Surgery | $13,246.50 |
Prescribed Ilizarov?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.